Celenys Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Liquidation

Celenys General Information

Description

Developer of hyaluronic acid based scaffolds designed for 3D cell culture. The company's hyaluronic acid based scaffolds are based on 3D study model for oncology and stem cell culture.

Contact Information

Website
www.celenys.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 75 route de Lyons la forêt
  • 76000 Rouen
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celenys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 07-Mar-2017 00.000 Completed Bankruptcy: Liquidation
1. Early Stage VC 30-Apr-2014 00.000 00.000 Completed Generating Revenue
To view Celenys’s complete valuation and funding history, request access »

Celenys Patents

Celenys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3035107-A1 Process for preparing hydrogel from modified hyaluronic acid and type i collagen Pending 15-Apr-2015 0000000000 0
FR-3023486-B1 Process for the chemical modification of polyetheramines, novel polyetheramines that can be obtained by this process, and the use of these polyetheramines Active 11-Jul-2014 00000000000
AU-2015287484-A1 Method for modifying polysaccharides by grafting polyetheramines, polysaccharides thus modified and preparations comprising same and having heat-sensitive rheological properties Inactive 11-Jul-2014 00000000000
CA-2954455-A1 Method for modifying polysaccharides by grafting polyetheramines, polysaccharides thus modified and preparations comprising same and having heat-sensitive rheological properties Inactive 11-Jul-2014 00000000000
FR-3023485-B1 Method of modifying polysaccharides by grafting polyetheramines, polysaccharides so modified, and preparations comprising them and having rheological properties thermosensitive Active 11-Jul-2014 C08B37/0018
To view Celenys’s complete patent history, request access »

Celenys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celenys FAQs

  • When was Celenys founded?

    Celenys was founded in 2013.

  • Who is the founder of Celenys?

    Nicolas Dubois and Elise Demange Ph.D are the founders of Celenys.

  • Where is Celenys headquartered?

    Celenys is headquartered in Rouen, France.

  • What is the size of Celenys?

    Celenys has 12 total employees.

  • What industry is Celenys in?

    Celenys’s primary industry is Biotechnology.

  • Is Celenys a private or public company?

    Celenys is a Private company.

  • What is Celenys’s current revenue?

    The current revenue for Celenys is 00000.

  • How much funding has Celenys raised over time?

    Celenys has raised $1.38M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »